Consolidated Balance Sheets - USD ($) $ in Millions	Jun. 30, 2015	Dec. 31, 2014
Current Assets
Cash and cash equivalents (variable interest entities restricted - 2015: $212; 2014: $190)	$ 6,224	$ 5,654
Accounts and notes receivable:
Trade (net of allowance for doubtful receivables - 2015: $114; 2014: $110)	4,957	4,685
Other	4,072	4,687
Inventories	8,061	8,101
Deferred income tax assets - current	982	812
Other current assets	468	328
Total current assets	24,764	24,267
Investments
Investment in nonconsolidated affiliates	4,272	4,201
Other investments (investments carried at fair value - 2015: $1,999; 2014: $2,009)	2,361	2,439
Noncurrent receivables	564	620
Total investments	7,197	7,260
Property
Property	55,280	55,230
Less accumulated depreciation	36,700	37,179
Net property (variable interest entities restricted - 2015: $2,657; 2014: $2,726)	18,580	18,051
Other Assets
Goodwill	12,358	12,632
Other intangible assets (net of accumulated amortization - 2015: $3,887; 2014: $3,737)	3,971	3,768
Deferred income tax assets - noncurrent	1,772	2,135
Asbestos-related insurance receivables - noncurrent	54	62
Deferred charges and other assets	638	621
Total other assets	18,793	19,218
Total Assets	69,334	68,796
Current Liabilities
Notes payable	436	551
Long-term debt due within one year	1,479	394
Accounts payable:
Trade	4,492	4,481
Other	2,199	2,299
Income taxes payable	664	361
Deferred income tax liabilities - current	131	105
Dividends payable	565	563
Accrued and other current liabilities	2,799	2,839
Total current liabilities	12,765	11,593
Long-Term Debt (variable interest entities nonrecourse - 2015: $1,123; 2014: $1,229)	17,833	18,838
Other Noncurrent Liabilities
Deferred income tax liabilities - noncurrent	557	622
Pension and other postretirement benefits - noncurrent	9,598	10,459
Asbestos-related liabilities - noncurrent	391	438
Other noncurrent obligations	3,423	3,290
Total other noncurrent liabilities	13,969	14,809
Redeemable Noncontrolling Interests	316	202
Stockholders’ Equity
Preferred stock, series A	4,000	4,000
Common stock	3,107	3,107
Additional paid-in capital	4,839	4,846
Retained earnings	24,606	23,045
Accumulated other comprehensive loss	(8,410)	(8,017)
Unearned ESOP shares	(284)	(325)
Treasury stock at cost	(4,246)	(4,233)
The Dow Chemical Company’s stockholders’ equity	23,612	22,423
Non-redeemable noncontrolling interests	839	931
Total equity	24,451	23,354
Total Liabilities and Equity	$ 69,334	$ 68,796